drugset
drugset / Trial / NCT02242734

Pharmacokinetics and Metabolism of Hydrocodone Bitartrate Controlled-Release (HC-CR) in Subjects With Hepatic Impairment

NCT02242734 ↗

Phase 1 Completed 30 enrolled Zogenix, Inc.
Non-randomizedParallel-groupOpen-labelOther

Summary

Determine the influence of hepatic impairment on the pharmacokinetics and metabolism of Hydrocodone Bitartrate Extended-Release (HC-ER) 20 mg capsules

Timeline

Start
2011-02
Primary completion
2011-05
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrocodone Unknown 20 mg —

Indications

No indication recorded.